(Q40181511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

title

Inhibitor of heat-shock protein 90 enhances the antitumor effect of DNA vaccine targeting clients of heat-shock protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Chi-Chen Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Cheng-Fen Tu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Ming-Chuan Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Wan-Jung Hsieh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Wen-Chang Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Wen-Tsang Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

Ming-Derg Lai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

404-410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235320 AND SRC:MED&resulttype=core&format=json

Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

The role of CD8( ) T cells in immune responses to colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

https://api.crossref.org/works/10.1038/SJ.MT.6300014

1 reference

7 January 2021

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021

https://api.crossref.org/works/10.1038/SJ.MT.6300014

1 reference

7 January 2021

Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

1 reference

https://api.crossref.org/works/10.1038/SJ.MT.6300014

7 January 2021